Sanofi (SNY)
44.32
-0.14
(-0.33%)
USD |
NASDAQ |
Sep 03, 16:00
44.32
0.00 (0.00%)
After-Hours: 20:00
Sanofi Research and Development Expense (TTM) : 9.453B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.453B |
| December 31, 2025 | 8.870B |
| June 30, 2025 | 8.358B |
| December 31, 2024 | 7.903B |
| June 30, 2024 | 7.428B |
| December 31, 2023 | 7.274B |
| June 30, 2023 | 7.056B |
| December 31, 2022 | 7.044B |
| June 30, 2022 | 6.953B |
| December 31, 2021 | 6.725B |
| June 30, 2021 | 6.558B |
| December 31, 2020 | 6.314B |
| June 30, 2020 | 6.345B |
| December 31, 2019 | 6.736B |
| June 30, 2019 | 6.973B |
| December 31, 2018 | 6.948B |
| June 30, 2018 | 6.629B |
| December 31, 2017 | 6.186B |
| June 30, 2017 | 5.805B |
| December 31, 2016 | 5.721B |
| June 30, 2016 | 5.758B |
| Date | Value |
|---|---|
| December 31, 2015 | 5.635B |
| June 30, 2015 | 5.893B |
| December 31, 2014 | 6.401B |
| June 30, 2014 | 6.449B |
| December 31, 2013 | 6.328B |
| June 30, 2013 | 6.249B |
| December 31, 2012 | 6.300B |
| June 30, 2012 | 6.587B |
| December 31, 2011 | 6.689B |
| June 30, 2011 | 6.149B |
| December 31, 2010 | 5.824B |
| June 30, 2010 | 6.272B |
| December 31, 2009 | 6.384B |
| June 30, 2009 | 6.371B |
| December 31, 2008 | 6.730B |
| June 30, 2008 | 6.689B |
| December 31, 2007 | 6.234B |
| June 30, 2007 | 5.843B |
| December 31, 2006 | 5.588B |
| June 30, 2006 | 5.237B |
| December 31, 2005 | 5.009B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AstraZeneca PLC | 14.21B |
| GSK Plc | 9.289B |
| Johnson & Johnson | 15.06B |
| Eli Lilly & Co. | 14.60B |
| Merck & Co., Inc. | 27.26B |